TAI · 9103.TW
Medtecs International Corporation Limited
NT$5.22-NT$0.26 (-4.74%)
Medtecs International Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
Loading market information…
TWO · 4116.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
BenQ Medical Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BenQ Medical Technology Corporation’s forward annual dividend is NT$2.00 per share, paid annual. The forward yield is 4.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow BenQ Medical Technology Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
BenQ Medical Technology Corporation operates as a multifaceted entity in the healthcare sector, providing a comprehensive range of services for medical equipment and consumables. This includes their manufacturing, assembly, maintenance, and repair, alongside their distribution through wholesale, retail, and leasing channels. The company serves markets across Taiwan, Mainland China, India, and other international regions. Its product portfolio features key offerings such as operating tables, surgical lights, ultrasound systems, medical and protective masks, medical display monitors, and IQOR integrated systems. Beyond its core medical device business, BenQ Medical also diversifies its operations into the wholesale and retail of information software, the sale of medical pharmaceuticals, the provision of management consultation services, and general trading activities. Established in 1989, the company initially operated as Trident Medical Corp. It rebranded to BenQ Medical Technology Corporation in June 2011 and is headquartered in Taipei, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:50 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$5.22-NT$0.26 (-4.74%)
Medtecs International Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
NT$23.35-NT$0.55 (-2.3%)
Wellell Inc.’s quoted price sits in the lower half of its reported 52-week range, 9.85% below the high.
NT$55.70+NT$0.80 (+1.46%)
TSH Biopharm Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
NT$31.45+NT$0.55 (+1.78%)
DIVA Laboratories, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.8% below the high.
NT$72.10-NT$0.40 (-0.55%)
Crystalvue Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 13.45% below the high.
NT$28.50-NT$0.15 (-0.52%)
Chi Sheng Pharma & Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 7.92% below the high.
NT$53.20-NT$0.20 (-0.37%)
Medical Imaging Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.06% below the high.
NT$32.15+NT$0.45 (+1.42%)
Lagis Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.57% below the high.
